1. Ending the HIV epidemic in the USA. Issue 7 (July 2020) Authors: Nichols, Brooke E; Kissler, Stephen M Journal: Lancet Issue: Volume 7:Issue 7(2020) Page Start: e454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Editorial Board. Issue 2 (February 2016) Journal: HIV medicine Issue: Volume 17:Issue 2(2016:Feb.) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Predictors of interest in taking pre‐exposure prophylaxis among men who have sex with men who used a rapid HIV‐testing site in Montreal (Actuel sur Rue). Issue 2 (14th July 2015) Authors: Lebouché, B; Engler, K; Machouf, N; Lessard, D; Thomas, R Journal: HIV medicine Issue: Volume 17:Issue 2(2016:Feb.) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Healthcare providers' knowledge of, attitudes to and practice of pre‐exposure prophylaxis for HIV infection. Issue 2 (14th July 2015) Authors: Desai, M; Gafos, M; Dolling, D; McCormack, S; Nardone, A Journal: HIV medicine Issue: Volume 17:Issue 2(2016:Feb.) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A simple self‐reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy. Issue 2 (17th July 2015) Authors: O'Connor, JL; Gardner, EM; Esser, S; Mannheimer, SB; Lifson, AR; Telzak, EE; Phillips, AN Journal: HIV medicine Issue: Volume 17:Issue 2(2016:Feb.) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HIV and new onset seizures: slipping through the cracks in HIV care and treatment. Issue 2 (22nd July 2015) Authors: Sikazwe, I; Elafros, MA; Bositis, CM; Siddiqi, OK; Koralnik, IJ; Kalungwana, L; Theodore, WH; Okulicz, JF; Potchen, MJ; Birbeck, GL Journal: HIV medicine Issue: Volume 17:Issue 2(2016:Feb.) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The ASSURE study: HIV‐1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir1. Issue 2 (14th July 2015) Authors: Wohl, DA; Bhatti, L; Small, CB; Edelstein, H; Zhao, HH; Margolis, DA; DeJesus, E; Weinberg, WG; Ross, LL; Shaefer, MS Journal: HIV medicine Issue: Volume 17:Issue 2(2016:Feb.) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Table of Contents. Issue 2 (February 2016) Journal: HIV medicine Issue: Volume 17:Issue 2(2016:Feb.) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV‐positive persons. Issue 2 (8th November 2015) Authors: Ryom, L; Boesecke, C; Gisler, V; Manzardo, C; Rockstroh, JK; Puoti, M; Furrer, H; Miro, JM; Gatell, JM; Pozniak, A; Behrens, G; Battegay, M; Lundgren, JD Journal: HIV medicine Issue: Volume 17:Issue 2(2016:Feb.) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immune activation in the course of HIV‐1 infection: Causes, phenotypes and persistence under therapy. Issue 2 (10th October 2015) Authors: Younas, M; Psomas, C; Reynes, J; Corbeau, P Journal: HIV medicine Issue: Volume 17:Issue 2(2016:Feb.) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗